Melissa Watson

Doctor of Osteopathic Medicine,  The Johns Hopkins Hospital 

Location: India

Consulting Services

Admin and Customer Support Scientific Writing Sales and Marketing

Areas Of Interest

Total Mastectomy Chromosome 8 RP56976 Pathogen-Free Organisms, Specific Pushkarmoola Detachment, Retinal Hemangioma, Sclerosing, Pulmonary Desmoplastic Medulloblastomas Choline Kinase Fistula, Arteriovenous Symptom Flareup Chickweed, Mouse-ear Extracellular Trap, Eosinophil Signal Transduction Pathways Deficiency, Factor Ten Angiomatoses Work, Rescue IL21R Platelet Counts Public Health Education for Professionals NADH-Glutamate Synthase Space, Subcellular Jernes Plaque Technique Oppenheims Disease Viruses, Satellite Proto Oncogene Proteins c maf Fas-Associating Protein FADD Bodies, Geniculate Centric Relation Turner Kieser Syndrome C-C Double Bond Isomerases Agents, Whitening Immunoglobulin lambda Chains Biofeedbacks Mollusc Venoms

Professional Narrative

Dr. Melissa Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Amgen 2012
Senior Director, Mayo Clinic 1987

Education

Doctor of medicine, Perelman School of Medicine 2012
Master of Science in physician assistant, Harvard Medical School 2016

Referees


Publications

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :